KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Treasury Shares (2016 - 2023)

Historic Treasury Shares for Moderna (MRNA) over the last 8 years, with Q4 2023 value amounting to $8.0 million.

  • Moderna's Treasury Shares fell 6521.74% to $8.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $8.0 million, marking a year-over-year decrease of 6521.74%. This contributed to the annual value of $8.0 million for FY2023, which is 6521.74% down from last year.
  • Latest data reveals that Moderna reported Treasury Shares of $8.0 million as of Q4 2023, which was down 6521.74% from $8.0 million recorded in Q3 2023.
  • Over the past 5 years, Moderna's Treasury Shares peaked at $23.0 million during Q4 2022, and registered a low of $1.0 million during Q1 2019.
  • Over the past 5 years, Moderna's median Treasury Shares value was $2.4 million (recorded in 2021), while the average stood at $5.6 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 79285.71% in 2022, then crashed by 6521.74% in 2023.
  • Quarter analysis of 5 years shows Moderna's Treasury Shares stood at $1.2 million in 2019, then soared by 86.03% to $2.2 million in 2020, then soared by 36.99% to $3.0 million in 2021, then skyrocketed by 666.67% to $23.0 million in 2022, then tumbled by 65.22% to $8.0 million in 2023.
  • Its last three reported values are $8.0 million in Q4 2023, $8.0 million for Q3 2023, and $8.0 million during Q2 2023.